Skip to main content

Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients

CBE ID
0658
Endorsed
New or Maintenance
Endorsement and Maintenance (E&M) Cycle
Is Under Review
No
Measure Description

Percentage of patients aged 50 years to 75 years receiving a screening colonoscopy without biopsy or polypectomy who had a recommended follow-up interval of at least 10 years for repeat colonoscopy documented in their colonoscopy report.

  • Measure Type
    Electronic Clinical Quality Measure (eCQM)
    Level Of Analysis
    Care Setting
    Numerator

    Patients who had a recommended follow-up interval of at least 10 years for repeat colonoscopy documented in their colonoscopy report

    Denominator

    All patients aged 50 years to 75 years and receiving screening a screening colonoscopy without biopsy or polypectomy

    Exclusions

    Documentation of medical reason(s) for not recommending at least a 10 year follow-up interval (eg, inadequate prep,familial or personal history of colonic polyps, patient had no adenoma and age is >= 66 years old, or life expectancy < 10 years, other medical reasons)

  • Most Recent Endorsement Activity
    Endorsed Prevention and Population Health Fall Cycle 2019
    Initial Endorsement
    Next Planned Maintenance Review
    Prevention and Population Health Fall 2023
    Endorsement Status
    Last Updated
  • Steward Organization Email
    Steward Organization Copyright

    The Measures are not clinical guidelines, do not establish a standard of medical care, and have not been tested for all potential applications.

    The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain.

    Commercial uses of the Measures require a license agreement between the user and the American Medical Association (AMA), [on behalf of the Physician Consortium for Performance Improvement® (PCPI®)] or the American Gastroenterological Association (AGA), or American Society for Gastrointestinal Endoscopy (ASGE) or the American College of Gastroenterology (ACG). Neither the AMA, AGA, ASGE, ACG, PCPI, nor its members shall be responsible for any use of the Measures.

    The AMA’s, PCPI’s and National Committee for Quality Assurance’s significant past efforts and contributions to the development and updating of the Measures is acknowledged. AGA, ASGE and ACG are solely responsible for the review and enhancement (“Maintenance”) of the Measures as of August 14, 2014.
    AGA, ASGE and ACG encourage use of the Measures by other health care professionals, where appropriate.

    THE MEASURES AND SPECIFICATIONS ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND.

    © 2019 American Medical Association, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy and American College of Gastroenterology. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use. For the Merit-Based Incentive Payment System, American Gastroenterological Association is the primary steward for measure revisions.
    Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, AGA, ASGE, ACG, the PCPI and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT®) or other coding contained in the specifications.

    CPT® contained in the Measures specifications is copyright 2004-2019 American Medical Association. LOINC® copyright 2004-2019 Regenstrief Institute, Inc. SNOMED CLINICAL TERMS (SNOMED CT®) copyright 2004-2019 College of American Pathologists. All Rights Reserved.